Anika Therapeutics (ANIK) announced that Stephen Griffin, current Executive Vice President, Chief Financial Officer and Chief Operating Officer, has been appointed President and Chief Executive Officer and a member of the Board of Directors, effective February 1, 2026. Griffin will succeed Cheryl Blanchard, Ph.D., who will become Executive Chair of the Board of Directors. In addition, John Henneman, III, Director since 2020, has been appointed Lead Independent Director.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential